adipofat

News and updates on obesity, nutrition and metabolism

[Mushtaq Bilal, PhD @MushtaqBilalPhD]

Don't use Sci-Hub — it's a "controversial" website with 84M+ research papers freely available.

We should all try to make billion-dollar academic publishers richer.

Anyway, here's a thread on how to integrate Sci-Hub with Zotero 7 to get free papers.

DO NOT DO IT!

[IIS Aragón @IISAragon]

🆕 Hoy conocemos de cerca a José Miguel Arbonés(@IISAragon/ @iacs_aragon)

👨‍🔬🔛 El investigador nos habla en esta entrevista sobre su labor dirigiendo el grupo @adipofat

🗣️ "La investigación puede ser desafiante y requiere perseverancia"

➕ℹ️https://t.co/0x75ncP7Q8

[Rosana Ferrero 📈📊🙌 @RosanaFerrero]

🔥¿Quieres crear gráficos impactantes fácilmente?
🤩 Elige tu estilo como un profesional
✅ ggplot2 https://t.co/8eY1N4Y9Qp
✅ bbplot https://t.co/CErBFsan1A
✅ ggthemes https://t.co/aZ4jBXB1Dc
✅ ggtech https://t.co/Fo7cXMQdju
#dataviz #RStats #datascience #data #analytics #code

[APS Publications @APSPublications]

New in our #PhysiologyofObesity collection in @AJPCellPhys:

CRISPR/Cas9-mediated deletion of adipocyte genes associated w/ NAFLD alters adipocyte lipid handling & reduces #steatosis in hepatocytes in vitro (Marta Lopez-Yus et al.)

https://t.co/Pe3pZ8tthi

@CIBER_OBN @adipofat

[Paolo Crosetto @PaoloCrosetto]

Ok this is big.

Web of Science just removed the MDPI flagship journal IJERPH from their lists. This means IJERPH has no more an Impact Factor.

Why is this big? What are the implications? 🧵

[Asociación Española para el Estudio del Hígado @AEEHLiver]

🔝¡Equipazo!
#livertwitter

[adipofat @adipofat]

@CIBER_OBN @SociedadSeedo @NeilFlochMD ✅ Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With #overweight or #obesity Without Diabetes
The STEP 8 Randomized Clinical Trial
https://t.co/IMtdCPr6El

[adipofat @adipofat]

The FDA approved a new indication for Wegovy (semaglutide) as anti-obesity medicine for teens with an initial BMI>= 95th percentile for age and sex
@CIBER_OBN
@SociedadSeedo
@NeilFlochMD

[adipofat @adipofat]

👁️ 👁️
People following a vegetarian lifestyle 🥦🍚 have around twice as many depressive episodes as meat-eaters🥩🍖, according to the Brazilian 🇧🇷 Longitudinal Study of Adult Health

https://t.co/zsFlUPCnHH
@pitiklinov
@NeilFlochMD

[adipofat @adipofat]

✅ Glucocorticoids, stress and eating: The mediating role of appetite-regulating hormones

https://t.co/29r1rml8vq

@SEEDO_Research
@sociedadSEEN

[adipofat @adipofat]

📍Once-Weekly Semaglutide in 201 Adolescents with #obesity

📍The mean change in BMI from baseline to week 68 was −16.1% with semaglutide and 0.6% with placebo ❗❗❗
https://t.co/tbPKjhH8vw
@SociedadSeedo
@NeilFlochMD

[adipofat @adipofat]

📍There is not such thing as "Science"
📍Science is a collection of methods and a mindset
📍Fed up of people claiming the authority of Science, like it's a big book you can open to find the right answer. That is simply wrong.

[adipofat @adipofat]

⏩ Adipose Tissue and Metabolic Balance - Virtual Collection

⏩ This collection covers reviews and original research papers form different areas linking physiology, molecular regulation, and cell biology

https://t.co/DBA0U699IL
@SEEDO_Research
@fgomollon

[adipofat @adipofat]

📍Proposal of an obesity classification based on weight history
👉🏻 Without knowing a person's history and other health indicators, a single point weight measurement, by itself, does little to understand a person's health.

https://t.co/jFwawTkRnr
@NeilFlochMD @SociedadSeedo

[adipofat @adipofat]

@StopWeightBias 👉🏻Take action
👉🏻Be part of the solution
#StopWeightBias

[adipofat @adipofat]

🏃🏻‍♀️⛹🏻‍♂️🤾🏻Protective effects of physical activity 🏋🏻🏌🏻‍♂️in colon #cancer and underlying mechanisms:
A review of epidemiological and biological evidence
https://t.co/4h32gOQZRF
@CristobMorales

[adipofat @adipofat]

👏👏👏The 2022 Lasker award honored Dr. Lauren Gardner @TexasDownUnder, who leads the team that built the Johns Hopkins COVID-19 global tracking map 👏👏👏https://t.co/0c9O22Wvoq)
@kikollan @AlbertoCairo

[adipofat @adipofat]

👉🏻Semaglutide treatment in a regular clinical setting was associated with weight loss similar to that seen in randomized clinical trials, which suggests its applicability for treating patients with #overweight or #obesity

https://t.co/jw0PupWDRw
@NeilFlochMD @SociedadSeedo

[adipofat @adipofat]

Social Media🗣️🐦 and Medical Misinformation.... a new viewpoint in @JAMA_current
https://t.co/8288a5uRD9
@fgomollon